{"product_id":"glow-blend-ghk-cu-bpc-157-tb-500-70mg-biolongevity-labs","title":"GLOW Blend (GHK-Cu, BPC-157, TB-500) X 70mg","description":"\u003cp\u003eDescription--The GLOW blend is a research‑grade peptide formulation combining GHK‑Cu, BPC‑157, and TB‑500 into a single vial for laboratory investigation. This synergistic blend is designed to support studies on tissue repair, vascular formation, and cellular signaling in vitro and ex vivo models. Each peptide contributes distinct regenerative mechanisms, offering complementary pathways for wound healing and recovery research.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanistic Claims\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK‑Cu (50 mg):\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eUp‑regulates wound healing processes.\u003c\/li\u003e\n\u003cli\u003eStimulates collagen and elastin production.\u003c\/li\u003e\n\u003cli\u003eEnhances angiogenic growth‑factor expression.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC‑157 (10 mg):\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eExhibits gastro‑protective and soft‑tissue repair properties.\u003c\/li\u003e\n\u003cli\u003eModulates nitric oxide signaling and growth‑factor receptor activity.\u003c\/li\u003e\n\u003cli\u003eBalances cytokine responses to reduce inflammation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB‑500 (10 mg):\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eSynthetic fragment of Thymosin Beta‑4.\u003c\/li\u003e\n\u003cli\u003ePromotes cell migration and angiogenesis.\u003c\/li\u003e\n\u003cli\u003eFunctions via actin‑sequestering and integrin‑linked pathways.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSynergistic Potential:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCopper‑mediated extracellular matrix activation (GHK‑Cu).\u003c\/li\u003e\n\u003cli\u003eCytoprotective signaling and anti‑inflammatory effects (BPC‑157).\u003c\/li\u003e\n\u003cli\u003eActin‑dependent cell motility and vascular formation (TB‑500).\u003c\/li\u003e\n\u003cli\u003eTogether, these mechanisms may enhance collagen deposition, angiogenic indices, and recovery metrics in controlled tissue injury models.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eResearch Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTissue repair and wound healing studies\u003c\/li\u003e\n\u003cli\u003eAngiogenesis and vascular biology investigations\u003c\/li\u003e\n\u003cli\u003eCellular signaling and extracellular matrix activation models\u003c\/li\u003e\n\u003cli\u003eIn vitro and ex vivo recovery assays\u003c\/li\u003e\n\u003cli\u003eExploratory regenerative medicine research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGLOW Blend Research Insights\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCombines three regenerative peptides into a single lyophilized formulation.\u003c\/li\u003e\n\u003cli\u003eDesigned for complementary activity across matrix activation, cytoprotection, and cell motility pathways.\u003c\/li\u003e\n\u003cli\u003eEvidence remains preclinical and exploratory, with promising activity in tissue repair and angiogenesis models.\u003c\/li\u003e\n\u003cli\u003eSupplied in freeze‑dried, filler‑free form to maximize stability and preserve chemical integrity.\u003c\/li\u003e\n\u003cli\u003eRecommended storage: reconstitute with sterile solvent prior to use; store aliquots at ≤ –20 °C to avoid repeated freeze–thaw cycles.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003c!--EndFragment --\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eResearch: GHK-Cu, BPC-157, and TB-500 (Thymosin Beta 4)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaboratory investigations of the GLOW peptide combination reveal synergistic mechanisms for cellular repair, vascular formation, and inflammatory modulation—valuable tools for in vitro research applications.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eAngiogenesis and Vascular Formation\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eBPC-157 demonstrates a unique mechanism by upregulating VEGFR2 expression without affecting VEGF-A levels. This unusual pathway activates the VEGFR2-Akt-eNOS signaling cascade in vascular endothelial cell cultures[1].\u003c\/p\u003e\n\u003cp\u003eGHK-Cu increased VEGF and bFGF expression by 230% in irradiated human dermal fibroblasts at nanomolar concentration[2]. Liposomal delivery systems showed 33.1% increased HUVEC proliferation rates with enhanced expression of cell cycle proteins[3].\u003c\/p\u003e\n\u003cp\u003eTB-500 acts as a potent endothelial cell chemoattractant, stimulating 4-6-fold increases in HUVEC migration[4]. The peptide’s seven amino acid sequence LKKTET shows activity at approximately 50 nanomolar concentration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eTissue Repair and Regeneration\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eThe actions of the GHK-Cu peptide include modulating 31.2% of human genes (4,192 genes) with ≥50% expression changes[5]. The peptide binds to integrin-linked kinase on cell membranes, activating ILK-related pathways.\u003c\/p\u003e\n\u003cp\u003eBPC-157 promotes tissue regeneration through FAK-paxillin pathway activation. This mechanism dramatically increases phosphorylation of focal adhesion kinase and paxillin proteins without changing total protein amounts[6].\u003c\/p\u003e\n\u003cp\u003eTB-500’s regenerative effects stem from G-actin sequestration activity—binding monomeric G-actin in a 1:1 ratio. Rat wound healing models demonstrated 42-61% increased reepithelialization with enhanced collagen deposition[7].\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eCollagen Synthesis and Extracellular Matrix\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eGHK-Cu stimulates collagen synthesis at picomolar to nanomolar concentrations[8]. The peptide increased decorin production by 302% and stimulated glycosaminoglycan accumulation in skin fibroblasts.\u003c\/p\u003e\n\u003cp\u003eBPC-157 enhances collagen formation across multiple tissue types in animal models. Studies show significantly increased collagen, reticulin, and blood vessel formation[9].\u003c\/p\u003e\n\u003cp\u003eTB-500 demonstrates anti-fibrotic properties while promoting organized collagen deposition. Treated wounds show tightly organized mature collagen fibers with reduced myofibroblast formation[10].\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eInflammatory Modulation\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eGHK-Cu works to reduce inflammation by inhibiting NF-κB p65 and p38 MAPK pathways. The peptide decreased ROS levels and reduced production of pro-inflammatory cytokines TNF-α and IL-6 in macrophage cell cultures[2].\u003c\/p\u003e\n\u003cp\u003eBPC-157 decreased TNF-α, IL-6, and IL-1β levels in tissue samples. The peptide reduced COX-2 gene expression and myeloperoxidase activity in various inflammation models[11].\u003c\/p\u003e\n\u003cp\u003eTB-500 exhibits biphasic regulation of the inflammatory response. The peptide downregulates TNF-α (6.2-fold reduction) and IL-6 (4.1-fold reduction) while upregulating anti-inflammatory IL-10 (8.1-fold increase)[12].\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eNeuroprotection and Neural Mechanisms\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eGHK-Cu increases production of nerve growth factor and neurotrophins NT-3 and NT-4[13]. Delivery showed enhanced spatial memory and learning navigation in aging models.\u003c\/p\u003e\n\u003cp\u003eBPC-157 demonstrates complex neurotransmitter system modulation[14]. The peptide interacts with dopaminergic systems without directly binding to dopamine receptors.\u003c\/p\u003e\n\u003cp\u003eTB-500 provides neuroprotection through anti-apoptotic effects via caspase-3 inhibition. The peptide promotes oligodendrocyte progenitor cell proliferation and differentiation through p38 MAPK upregulation[15].\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eCellular Migration and Proliferation\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eTB-500’s G-actin sequestration represents the primary mechanism for cellular migration[7]. Local photorelease of caged TB-500 causes directional cell turning in locomoting keratocytes.\u003c\/p\u003e\n\u003cp\u003eGHK-Cu acts as a potent chemoattractant for macrophages, mast cells, and capillary endothelial cells[16]. Irradiated fibroblasts treated with GHK showed growth dynamics similar to non-irradiated control cells.\u003c\/p\u003e\n\u003cp\u003eBPC-157 regulates cellular migration through ERK1\/2 phosphorylation[17]. Downstream transcription factors showed dramatic upregulation: c-Fos by 4.99-fold, c-Jun by 7.05-fold, and Egr-1 by 3.70-fold.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eWound Healing Mechanisms\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eBPC-157 demonstrates route-independent efficacy. The peptide accelerates cellular repair phases including inflammation, collagen deposition, angiogenesis, and epithelial repair[9].\u003c\/p\u003e\n\u003cp\u003eGHK-Cu enhances wound healing through systemic effects and local tissue remodeling. Collagen dressing with incorporated GHK resulted in faster wound contraction and higher glutathione and ascorbic acid levels[5].\u003c\/p\u003e\n\u003cp\u003eTB-500 promotes organized wound repair with anti-scarring properties. The peptide enhanced wound contraction by 11% and increased reepithelialization by 42-61% in full-thickness wound models[10].\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eOxidative Stress Response\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eGHK-Cu demonstrates potent ROS reduction in cell cultures[18]. The peptide increased superoxide dismutase activity and quenched hydroxyl and peroxyl radicals.\u003c\/p\u003e\n\u003cp\u003eTB-500 provides targeted upregulation of antioxidant enzymes[11]. Pretreatment reduced intracellular ROS levels and upregulated Cu\/Zn-SOD and catalase.\u003c\/p\u003e\n\u003cp\u003eBPC-157 functions as a free radical scavenger. The peptide normalizes nitric oxide and malondialdehyde levels while increasing expression of antioxidant enzymes heme oxygenase-1 and NOS-3[11].\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThese peptides are intended for in vitro laboratory research purposes only and are not intended for human consumption or therapeutic use.\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eM.-J. Hsieh \u003cem\u003eet al.\u003c\/em\u003e, “Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation,” Springer Science and Business Media LLC, Nov. 2016. doi: 10.1007\/s00109-016-1488-y. Available:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.1007\/s00109-016-1488-y\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1007\/s00109-016-1488-y\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eY. Dou, A. Lee, L. Zhu, J. Morton, and W. Ladiges, “The potential of GHK as an anti-aging peptide,” Ant Publishing, Mar. 2020. doi: 10.31491\/apt.2020.03.014. Available: \u003ca href=\"https:\/\/doi.org\/10.31491\/apt.2020.03.014\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.31491\/apt.2020.03.014\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eX. Wang \u003cem\u003eet al.\u003c\/em\u003e, “GHK‐Cu‐liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis,” Wiley, Apr. 2017. doi: 10.1111\/wrr.12520. Available:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.1111\/wrr.12520\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1111\/wrr.12520\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eK. M. Malinda, A. L. Goldstein, and H. K. Kueinman, “Thymosin β            4            stimulates directional migration of human umbilical vein endothelial cells,” Wiley, May 1997. doi: 10.1096\/fasebj.11.6.9194528. Available:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eL. Pickart and A. Margolina, “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data,” MDPI AG, Jul. 2018. doi: 10.3390\/ijms19071987. Available: \u003ca href=\"https:\/\/doi.org\/10.3390\/ijms19071987\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.3390\/ijms19071987\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eC.-H. Chang, W.-C. Tsai, M.-S. Lin, Y.-H. Hsu, and J.-H. S. Pang, “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration,” American Physiological Society, Mar. 2011. doi: 10.1152\/japplphysiol.00945.2010. Available: \u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eB. Xue, C. Leyrat, J. M. Grimes, and R. C. Robinson, “Structural basis of thymosin-β4\/profilin exchange leading to actin filament polymerization,” Proceedings of the National Academy of Sciences, Oct. 2014. doi: 10.1073\/pnas.1412271111. Available: \u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.1412271111\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1073\/pnas.1412271111\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eF.-X. Maquart, L. Pickart, M. Laurent, P. Gillery, J.-C. Monboisse, and J.-P. Borel, “Stimulation of collagen synthesis in fibroblast cultures by the tripeptide‐copper complex glycyl‐L‐histidyl‐L‐lysine‐Cu2+,” Wiley, Oct. 1988. doi: 10.1016\/0014-5793(88)80509-x. Available: \u003ca href=\"https:\/\/doi.org\/10.1016\/0014-5793(88)80509-x\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1016\/0014-5793(88)80509-x\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eS. Seiwerth \u003cem\u003eet al.\u003c\/em\u003e, “Stable Gastric Pentadecapeptide BPC 157 and Wound Healing,” Frontiers Media SA, Jun. 2021. doi: 10.3389\/fphar.2021.627533. Available:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.3389\/fphar.2021.627533\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.3389\/fphar.2021.627533\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eK. M. Malinda \u003cem\u003eet al.\u003c\/em\u003e, “Thymosin beta4 accelerates wound healing.,”\u003cspan\u003e \u003c\/span\u003e\u003cem\u003eJournal of Investigative Dermatology\u003c\/em\u003e, vol. 113 3, pp. 364–8, 1999.\u003c\/li\u003e\n\u003cli\u003eH. Demirtaş, A. Özer, A. K. Yıldırım, A. D. Dursun, Ş. C. Sezen, and M. Arslan, “Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia–Reperfusion Injury,” MDPI AG, Feb. 2025. doi: 10.3390\/medicina61020291. Available: \u003ca href=\"https:\/\/doi.org\/10.3390\/medicina61020291\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.3390\/medicina61020291\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eM. A. Evans \u003cem\u003eet al.\u003c\/em\u003e, “Thymosin β4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healing,” Springer Science and Business Media LLC, Jul. 2013. doi: 10.1038\/ncomms3081. Available:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/ncomms3081\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1038\/ncomms3081\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eL. Pickart, J. M. Vasquez-Soltero, and A. Margolina, “The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health,” Hindawi Limited, 2012. doi: 10.1155\/2012\/324832. Available: \u003ca href=\"https:\/\/doi.org\/10.1155\/2012\/324832\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1155\/2012\/324832\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eJ. Vukojevic \u003cem\u003eet al.\u003c\/em\u003e, “Pentadecapeptide BPC 157 and the central nervous system,” Medknow, 2022. doi: 10.4103\/1673-5374.320969. Available:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.4103\/1673-5374.320969\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.4103\/1673-5374.320969\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eS. Kim, J. Choi, and J. Kwon, “Thymosin Beta 4 Protects Hippocampal Neuronal Cells against PrP (106–126) via Neurotrophic Factor Signaling,” MDPI AG, May 2023. doi: 10.3390\/molecules28093920. Available:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.3390\/molecules28093920\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.3390\/molecules28093920\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eL. Pickart, J. M. Vasquez-Soltero, and A. Margolina, “GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration,” Wiley, 2015. doi: 10.1155\/2015\/648108. Available:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.1155\/2015\/648108\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1155\/2015\/648108\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eT. Huang \u003cem\u003eet al.\u003c\/em\u003e, “Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro,” Informa UK Limited, Apr. 2015. doi: 10.2147\/dddt.s82030. Available:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/doi.org\/10.2147\/dddt.s82030\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.2147\/dddt.s82030\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eS. Sharma, M. F. Anwar, A. Dinda, M. Singhal, and A. Malik, “In Vitro and in Vivo Studies of pH-Sensitive GHK-Cu-Incorporated Polyaspartic and Polyacrylic Acid Superabsorbent Polymer,” American Chemical Society (ACS), Nov. 2019. doi: 10.1021\/acsomega.9b00655. Available: \u003ca href=\"https:\/\/doi.org\/10.1021\/acsomega.9b00655\" rel=\"noopener\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1021\/acsomega.9b00655\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003eLabel--\u003cstrong\u003ePeptide Information\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003cstrong\u003eProperty\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSequence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e Gly-His-Lys.Cu.xHAc\u003c\/td\u003e\n\u003ctd\u003eGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val\u003c\/td\u003e\n\u003ctd\u003eAc-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eC₁₄H₂₃CuN₆O₄\u003c\/td\u003e\n\u003ctd\u003eC₆₂H₉₈N₁₆O₂₂\u003c\/td\u003e\n\u003ctd\u003eC₂₁₂H₃₅₀N₅₆O₇₈S\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e401.91 g\/mol\u003c\/td\u003e\n\u003ctd\u003e1419.5 g\/mol\u003c\/td\u003e\n\u003ctd\u003e4963.55 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePubChem CID\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e73587\u003c\/td\u003e\n\u003ctd\u003e9941957\u003c\/td\u003e\n\u003ctd\u003e16132341\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCAS Number\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e89030-95-5\u003c\/td\u003e\n\u003ctd\u003e137525-51-0\u003c\/td\u003e\n\u003ctd\u003e77591-33-4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSynonyms\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCopper peptide GHK, Cu-GHK, NSC 661251\u003c\/td\u003e\n\u003ctd\u003ePL-14736, Body-Protection Compound-157, Bepecin\u003c\/td\u003e\n\u003ctd\u003eThymosin-β4 fragment 17-23, TB-500 acetate, Ac-LKKTETQ\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eDosage--\u003cstrong\u003eThis PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.\u003c\/strong\u003e\u003cspan\u003e This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only.  This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.\u003c\/span\u003e\u003c\/p\u003e","brand":"Biolongevity Labs","offers":[{"title":"Default Title","offer_id":47947414208667,"sku":"BPC-TB5-GHK-70MG","price":30658.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3694\/4795\/files\/BPC-TB5-GHK-70MG-glow-blend-ghk-cu-bpc-157-tb-500-70mg-RET.jpg?v=1770933379","url":"https:\/\/fmihealth.com\/products\/glow-blend-ghk-cu-bpc-157-tb-500-70mg-biolongevity-labs","provider":"FMI health","version":"1.0","type":"link"}